Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Molly Glaze

Clinical Trial Manager

I run three surgical feasibility studies in the Surgical Interventions Trials Unit (SITU):


PARCS is a mixed methods feasibility study. Its aim is to determine the design of a definitive randomised trial assessing the effectiveness and cost-effectiveness of a patch to augment surgical repair of the rotator cuff tendon that is both feasible and acceptable to stakeholders.


STIFF-F is a feasibility study to assess the practicability of a multicentre randomised controlled trial comparing intramedullary nailing (IN) with circular frame external fixation (CFEF) in patients with segmental tibial fractures.


SPINOUT-F is a feasibility study to inform the design and conduct of a multicentre randomised controlled trial of decompression with instrumented fusion compared to decompression only in patients with a specific type of spinal stenosis.


Prior to this role I worked as a Clinical Trial Assistant in the Oxford Respiratory Trials Unit, and as a Trainee Clinical Trial Manager with OCTRU. I graduated from Oxford University with a Masters degree in Biochemistry.